Becerra voices support for additional Provider Relief Funding

Feb 23, 2021 - 02:14 PM
senate-hearing-rountable

At a Senate Health, Education, Labor and Pensions Committee hearing today on his nomination to serve as Health and Human Services Secretary, Xavier Becerra said he supports additional COVID-19 funding for health care providers.

The comments came during questioning from Sen. Susan Collins, R-Maine, who urged Becerra to consider additional funding for the Provider Relief Fund. Among other comments made during the hearing, Becerra called the 340B Drug Pricing Program “indispensable” to providers serving the neediest patients

The AHA last week sent letters to leaders of the Senate HELP and Finance committees expressing the association’s support for Becerra to be the next HHS Secretary. The Finance Committee tomorrow will hold a hearing on his confirmation.

Related News Articles

Blog
RAND 5.0 – The Health Policy Equivalent of Groundhog Day
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
CDC encourages older adults to get additional COVID-19 vaccine dose 
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
NASEM releases evidence review on COVID-19 vaccine safety
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
FDA approves combo test for flu, COVID-19; alerts providers to medical device risks 
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
CDC recommends additional dose of updated COVID-19 vaccine for older adults
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
FDA: Paxlovid no longer labeled for emergency use after March 8
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…